Implementation Guide CH VACD
5.0.0-ci-build - ci-build
Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions
Generated Narrative: Immunization TCF01-IMMUN2
Author of the content: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
CH VACD Extension Immunization Medication Reference: Medication HAVRIX 1440 Inj Susp
Entry Resource Cross References
- entry: Identifier:
urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/855bdd69-0a39-4241-b208-9b248a62fb76- container: Identifier: URI/urn:uuid:e2233a2f-d1c2-459d-b4fe-4920c35339e7
- relationcode: replaces
identifier: urn:oid:2.16.756.5.30.1.402.1.3.1.1.1
/e2233a2f-d1c2-459d-b4fe-4920c35339e7
status: Completed
vaccineCode: Havrix 1440
patient: Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)
occurrence: 2021-05-27
recorded: 2021-05-27 00:00:00+0200
lotNumber: AHAVB946A
route: Intramuscular use
Actor |
PractitionerRole |
note: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)
TargetDisease | DoseNumber[x] |
Viral hepatitis, type A (disorder) | 1 |